ConductScience.org, home

Paper7366673

Cholestyramine promotes receptor-mediated low-density-lipoprotein catabolism.

Shepherd J and 4 others. N Engl J Med, 1980. Cited by 343 papers, by iCite.

Cite this record

ConductScience Library. Cholestyramine promotes receptor-mediated low-density-lipoprotein catabolism. Papers, record 7366673. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7366673

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Cholestyramine promotes receptor-mediated low-density-lipoprotein catabolism.
PubMed
Journal
N Engl J Med
PubMed
Year
1980
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
343
iCite
Relative citation ratio, by iCite
12.2
iCite
Revised in PubMed
2013-11-21
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Shepherd JJ
2Packard CJC J
3Bicker SS
4Lawrie TDT D
5Morgan HGH G

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cholestyramine ResinMajor topic
Hyperlipoproteinemia Type IIMajor topic
Lipoproteins, LDLMajor topic
Receptors, DrugMajor topic
Adult
Aged
Cholesterol
Heterozygote
Humans
Middle Aged

Source PubMed

Download CSV of topics

Trials2

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's recordSource
NCT00476710Effects of Colesevelam HCl On Bile Acid KineticsBackgroundClinicalTrials.gov
NCT00596427Mechanisms of Glucose Lowering Effect of Colesevelam HClBackgroundClinicalTrials.gov

Download CSV of trials

Cited by57

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 343 citations.

PMIDTitleJournalYearIn PapersSource
27570415Mechanisms of triglyceride metabolism in patients with bile acid diarrhea.World J Gastroenterol2016https://conductscience.org/library/papers/27570415PubMed
26045273Impact of Inhibiting Ileal Apical versus Basolateral Bile Acid Transport on Cholesterol Metabolism and Atherosclerosis in Mice.Dig Dis2015https://conductscience.org/library/papers/26045273PubMed
25628509Patient tolerance and acceptance of colesevelam hydrochloride: focus on type-2 diabetes mellitus.P T2015https://conductscience.org/library/papers/25628509PubMed
25061583Dyslipidemia in children and adolescents: when and how to diagnose and treat?Pediatr Gastroenterol Hepatol Nutr2014https://conductscience.org/library/papers/25061583PubMed
24058856The impact of mitochondrial oxidative stress on bile acid-like molecules in C. elegans provides a new perspective on human metabolic diseases.Worm2013https://conductscience.org/library/papers/24058856PubMed
23754124A reappraisal of the risks and benefits of treating to target with cholesterol lowering drugs.Drugs2013https://conductscience.org/library/papers/23754124PubMed
23677836Challenges in the pharmacologic management of obesity and secondary dyslipidemia in children and adolescents.Paediatr Drugs2013https://conductscience.org/library/papers/23677836PubMed
22438816Mitochondrial oxidative stress alters a pathway in Caenorhabditis elegans strongly resembling that of bile acid biosynthesis and secretion in vertebrates.PLoS Genet2012https://conductscience.org/library/papers/22438816PubMed
21938413Familial hypercholesterolemia: present and future management.Curr Cardiol Rep2011https://conductscience.org/library/papers/21938413PubMed
19875558Bile acids and metabolic regulation: mechanisms and clinical responses to bile acid sequestration.Diabetes Care2009https://conductscience.org/library/papers/19875558PubMed
18950282Cholesterol-metabolizing cytochromes P450: implications for cholesterol lowering.Expert Opin Drug Metab Toxicol2008https://conductscience.org/library/papers/18950282PubMed
18633604Cytochrome P450 and gene activation--from pharmacology to cholesterol elimination and regression of atherosclerosis.Eur J Clin Pharmacol2008https://conductscience.org/library/papers/18633604PubMed
17315604Optimal lipid modification: the rationale for combination therapy.Vasc Health Risk Manag2005https://conductscience.org/library/papers/17315604PubMed
15509187Effect of colesevelam HCl on single-dose fenofibrate pharmacokinetics.Clin Pharmacokinet2004https://conductscience.org/library/papers/15509187PubMed
10529092Effects of cholestyramine on hepatic cholesterol 7alpha-hydroxylase and serum 7alpha-hydroxycholesterol in the hamster.Lipids1999https://conductscience.org/library/papers/10529092PubMed
9046034Hypolipidemic action of curcumin, the active principle of turmeric (Curcuma longa) in streptozotocin induced diabetic rats.Mol Cell Biochem1997https://conductscience.org/library/papers/9046034PubMed
8735642Preservation of endothelium-dependent relaxation in cholesterol-fed and streptozotocin-induced diabetic mice by the chronic administration of cholestyramine.Br J Pharmacol1996https://conductscience.org/library/papers/8735642PubMed
8347487Low density lipoprotein for cytotoxic drug targeting: improved activity of elliptinium derivative against B16 melanoma in mice.Br J Cancer1993https://conductscience.org/library/papers/8347487PubMed
8251323Hyperlipidemia in childhood nephrotic syndrome.Pediatr Nephrol1993https://conductscience.org/library/papers/8251323PubMed
7085881Significance of low density lipoprotein production in the regulations of plasma cholesterol level in man.J Clin Invest1982https://conductscience.org/library/papers/7085881PubMed

See all 57 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7366673

GET https://conductscience.org/api/papers/v1/7366673/cited_by?page=2